Houlihan Lokey's stock price plummeted 5.25% during intraday trading on Thursday, as the market reacted to a series of analyst research actions on the investment bank.

The decline followed target price cuts from several major firms. Morgan Stanley trimmed its price target on Houlihan Lokey to $205 from $215, while maintaining an Overweight rating. Similarly, KBW reduced its target price to $214 from $218.

These downward revisions offset more positive analyst sentiment, including BMO Capital raising its target price to $211 from $209 and maintaining an Outperform rating. According to FactSet data, Houlihan Lokey maintains an average rating of overweight with a mean price target of $206.25 among analysts.